Delivery Order SPE2DB24D3015-SPE2DB25FFWWE

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,531.81. The contract is a firm fixed price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. federal government. The $5,911.83 firm-fixed-price order is for the supply of MOVANTIK 25 MG TABLET 30S, a prescription medication. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,632.62 firm fixed price delivery order is for the supply of 4567445213 - MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $6,470.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The order has an ultimate completion date of August 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,551.92, is for the delivery of MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 5, 2024. The contract is not set aside for any specific socioeconomic group....
This is a delivery order award to Amerisourcebergen Drug Corp under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The specific order is for the pharmaceutical product MOVANTIK 25 MG TABLET 30S, with a firm fixed price of $1,327.18 and a completion date of August 6, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, was awarded this order as part of its extensive IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $7,373.23, is for the delivery of MOVANTIK 25 MG TABLET 30S medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the prescription medication Movantik 25 mg Tablet 30s, with a ceiling value of $1,754.76 and a completion date of September 4, 2024. This is not a set-aside contract. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,116.80, is for the supply of 4567490665 MOVANTIK 25 MG TABLET 30S, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was awarded through open competition. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOVANTIK 25 MG TABLET 30S. The contract, valued at $1,951.24, is a delivery order that runs through May 3, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a for-profit organization registered in the System for Award Management (SAM.gov). The contract does not have a set-aside...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFWWE
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,260.21 firm fixed-price contract is for the delivery of MOVANTIK 25 MG TABLET UD 100S, a prescription medication, with a performance period through October 31, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with both the DLA Troop Support Medical, valued at $999,999,999 through November 2026, and the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024. These IDCs enable the company to efficiently provide a comprehensive range of pharmaceutical products and medical supplies to support various federal healthcare programs, including those serving military personnel, veterans, and other federal beneficiaries.

Generated 1/29/25, 9:17 AM